Our partner MUNIT has announced that it will soon participate in the following events:
- 6th Annual Highly Potent Active Pharmaceutical Ingredients Online Summit (10-11 marzo 2021)
This event will enable the participants to learn about the latest developments in the HPAPI Industry. This Summit will be focusing on latest market development trends in the highly potent active pharmaceutical ingredients, global standards, innovation challenges & expectations, sustainability, emerging markets, future trends & technological developments, etc.
Please book your participation now here: https://www.vonlanthenevents.com/en/6th-annual-highly-potent-active-pharmaceutical-ingredients-online-summit
Respiratory Drug Delivery 2021 (RDD 2021) is the must attend, premier international conference for researchers, regulators, business professionals and suppliers active in pulmonary and nasal drug delivery. While the global pandemic is keeping us physically apart, RDD 2021 is evolving to bring us closer in a new virtual format. Gone are separate rooms for podium, workshop, exhibition and poster sessions. Welcome to on-screen Knowledge Spaces, where quality curated science and services are arranged by theme.
Prenota ora la tua partecipazione qui: https://www.rddonline.com/ rdd / rdd.php? id = 20 & amp; sid = 2
- 12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology ( 11-14 maggio 2021)
In continuation of the very successful scientific meetings in Budapest, Paris, Berlin, Florence, Geneva, Barcelona, Malta, Istanbul, Lisbon, Glasgow and Granada, the 12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology will be held as a virtual conference due to the SARS-CoV-2 pandemic in 2021. This conference has gained an ever increasing impact among the pharmaceutical scientists: With more than 1000 submitted abstracts and about 1300 participants it has become a well-established major meeting, attracting scientists from all over the world. The entire spectrum of topics, ranging from engineering aspects during the manufacturing process, the portfolio of commercially available excipients enabling formulation of a large variety of medicinal products, the underlying physico-chemical principles, cutting-edge characterization techniques as well as potential pitfalls and hurdles to be overcome during product development, manufacturing and characterisation will be addressed.
